Hattie Hayes is the editor of Ophthalmology Times Europe.
The 36th annual International Congress of German Ophthalmic Surgery (DOC) comes to Nuremberg
Sustainability, artificial intelligence and economic considerations are hot topics at this year’s meeting
NIDEK announces CE mark for IOL injector, launch of new OCT device
The NP-1/NP-1C preloaded IOL injector has already been made available in parts of Asia
Recap: The Association for Research in Vision and Ophthalmology takes Seattle
ARVO attendees took a deep dive into trends and explored the near future of vision science
Espansione Group receives CE Mark approval for eye-light® photobiomodulation device
The flagship, light-based technology has received approval for applications in the anterior and posterior segments
Global leaders in cataract run the Olympic gauntlet of surgery
Surgeons shared practical pearls in a “Cataract Olympiad"
The 16th European Glaucoma Society Congress convenes in Dublin
This year’s meeting will take place in Ireland’s technology and business hub
European Commission grants Marketing Authorisation for bevacizumab gamma
The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)
Professor Noemi Lois awarded Edinburgh King James IV Professorship by The Royal College of Surgeons
Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress
United States FDA approves two aflibercept 2 mg biosimilars
The agency issued approval for Yesafili, from Biocon Biologics, and Opuviz, from Samsung Bioepis and Biogen
Outlook Therapeutics submits UK Marketing Authorisation Application for wet AMD treatment
The submission for bevacizumab gamma (ONS-5010/LYTENAVA) follows a positive opinion from the CHMP in March
Going beyond the clinical setting in ophthalmic mentorship
Three leaders in glaucoma research, retina care and refractive surgery share their expertise
ARVO 2024: Taking stock of patients' nAMD experience using an activity inventory
Antonio Filipe Macedo, OD, MSc, PhD, speaks about his ARVO presentation on vision-related activity difficulties in patients with neovascular age-related macular degeneration
ARVO 2024: Using objective measures to gauge activity levels of visually-impaired children
New research findings presented at this year's ARVO meeting compare two groups of paediatric patients in Nepal
ARVO 2024: New research indicates the need for a new approach to central vision loss
Susana Chung, OD, PhD, speaks about one of her ARVO presentations and the future of artificial intelligence in eye care
ARVO 2024: Updates from the BLINK2 study on contact lens wear and axial length growth
At this year's ARVO meeting, new data from the BLINK2 study show axial growth rates after discontinuing soft multifocal contact lens wear
ARVO 2024: How delayed onset of vision impairment alters auditory distance estimation
Age of vision loss onset has a stark impact on patients’ auditory processing and sensory substitution
Retina community mourns sudden loss of Ramin Tadayoni, MD, PhD
Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President
Amniotic membrane could move the needle outside of the operating room
The tissue serves as a testing ground for outpatient ocular therapies
ASCRS 2024: MIGS data is outpacing "human intelligence," driving calls for AI
David Lubeck, MD, talks about the biggest surprises from ASCRS in the glaucoma space
Clinicians and researchers don’t shy away from hot topics in the field
The 15th annual Congress on Controversies in Ophthalmology heads to Athens, Greece
ASCRS 2024: Real-world results with an enhanced monovision toric lens
Josefina Botta, MD, MSc, discusses her real-world experiences with the RayOne EMV toric lens
SCHWIND appoints new head of global marketing solutions
Lohith Shetty will lead marketing for the company, based in Kleinostheim, Germany
ASCRS 2024: First-in-human data from Centricity Vision's ZEPTOLink IOL positioning system
The technology, which creates a 360-degree, instantaneous capsulotomy, appeared at the Eyecelerator event
ASCRS 2024: Two papers demonstrate medication burden reduction and safety of a microcatheter for glaucoma
Dr Nir Shoham-Hazon presented two papers detailing outcomes from the iTrack microcatheter at ASCRS in Boston
ASCRS 2024: A case report on human corneal endothelial cell transplantation combined with cataract extraction and PCIOL
Elizabeth Yeu, MD, discusses a corneal case report at ASCRS 2024
ASCRS 2024: A retrospective study shows iStent's impact on medication burden in surgical and non-surgical patient groups
At ASCRS, Dr Rom Kandavel discusses iStent outcomes for patients who have undergone laser peripheral iridotomy, trabeculectomy and SLT
ASCRS 2024: Pearls of clinical and non-clinical wisdom for young eye surgeons
At this year's ASCRS meeting, J. Morgan Micheletti, MD, talks about his research and the Young Eye Surgeons (YES) programme
ASCRS 2024: IOLs, binocularity and stereoacuity in aperture optics
William F. Wiley, MD, shares key takeaways from his presentation on binocularity and stereoacuity
ASCRS 2024: Transforming how we think about IOL calculation with Light Adjustable Lens technology
Dr Neda Nikpoor discusses Light Adjustable Lenses and the implications for clinicians at ASCRS 2024
ASCRS 2024: International data are forthcoming in corneal endothelial disease treatment
At ASCRS 2024, Aurion Biotech's Global VP Eris Jordan previews upcoming clinical data from North America and Asia